Posters
Optimisation of cataract surgery with Mydrane in a real-life setting and economic impact
Poster Details
First Author: R.Simons NETHERLANDS
Co Author(s): L. Rondas F. van den Biggelaar R. de Crom T. Berendschot R. Nuijts
Abstract Details
Purpose:
Adequate mydriasis and pain control are essential during cataract surgery. Mydrane (combination of tropicamide, phenylephrine, and lidocaine) is a novel product that is injected intracamerally at the beginning of cataract surgery to achieve fast and stable mydriasis and to reduce intraoperative pain. In addition, it avoids the need for preoperative topical mydriatics. As a result, use of Mydrane may result in safer cataract surgery procedures, better patient comfort, and improved efficiency. The aim of this study is to evaluate the economic impact of implementation of Mydrane in a real-life setting compared to topical mydriatics and Mydriasert.
Setting:
Two ophthalmology clinics in the Netherlands.
Methods:
A total of 340 patients undergoing routine cataract surgery under topical anesthesia will be included in the study prospectively. Patients with foreseen incomplete mydriasis or ophthalmic disorders other than cataract will be excluded. Mydriasis will be achieved using topical mydriatics, Mydriasert, or Mydrane. The main outcome is incremental healthcare costs (based on e.g., medication costs, surgery duration, use of additional mydriatic medication/instruments intraoperatively, personnel costs for administering topical mydriatics). Other outcomes include patient-reported outcome measures (Catquest-9SF, pain), surgeon-reported satisfaction with mydriasis and visualization, and time until complete mydriasis.
Results:
The results of the study will be presented at this year’s ESCRS congress.
Conclusions:
The results of the study will be presented at this year’s ESCRS congress.
Financial Disclosure:
... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, ... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented
